NL7102519A - - Google Patents
Info
- Publication number
- NL7102519A NL7102519A NL7102519A NL7102519A NL7102519A NL 7102519 A NL7102519 A NL 7102519A NL 7102519 A NL7102519 A NL 7102519A NL 7102519 A NL7102519 A NL 7102519A NL 7102519 A NL7102519 A NL 7102519A
- Authority
- NL
- Netherlands
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
- C07D239/10—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Joining Of Building Structures In Genera (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1698270A | 1970-03-05 | 1970-03-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL7102519A true NL7102519A (cg-RX-API-DMAC10.html) | 1971-09-07 |
Family
ID=21780073
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL7102519A NL7102519A (cg-RX-API-DMAC10.html) | 1970-03-05 | 1971-02-25 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US3681349A (cg-RX-API-DMAC10.html) |
| AT (1) | AT305288B (cg-RX-API-DMAC10.html) |
| BE (1) | BE763745A (cg-RX-API-DMAC10.html) |
| CH (1) | CH555343A (cg-RX-API-DMAC10.html) |
| DE (1) | DE2110445C3 (cg-RX-API-DMAC10.html) |
| DK (1) | DK127427B (cg-RX-API-DMAC10.html) |
| ES (1) | ES388780A1 (cg-RX-API-DMAC10.html) |
| FR (1) | FR2085673B1 (cg-RX-API-DMAC10.html) |
| GB (1) | GB1294626A (cg-RX-API-DMAC10.html) |
| IL (1) | IL36189A0 (cg-RX-API-DMAC10.html) |
| NL (1) | NL7102519A (cg-RX-API-DMAC10.html) |
| NO (1) | NO130728C (cg-RX-API-DMAC10.html) |
| SE (1) | SE376420B (cg-RX-API-DMAC10.html) |
| ZA (1) | ZA71928B (cg-RX-API-DMAC10.html) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL39003A (en) * | 1971-03-25 | 1975-02-10 | Morton Norwich Products Inc | 1-(substituted benzyl)tetrahydro-2-(1h)-pyrimidones and their preparation |
| US3957785A (en) * | 1971-12-02 | 1976-05-18 | Societa' Farmaceutici Italia S.P.A. | Bβ-Pyrimidino-aminomethyl-10α-ergoline and 10α-methoxyergoline derivatives |
| US3956325A (en) * | 1974-01-21 | 1976-05-11 | Smithkline Corporation | 5-Heterocyclic-1,2,3,6-tetrahydro-4(5H) pyrimidinone |
| US4003900A (en) * | 1976-03-11 | 1977-01-18 | Morton-Norwich Products, Inc. | 1-Benzyl-5-chloro-2-(1H)-pyrimidone |
| US4002627A (en) * | 1976-03-26 | 1977-01-11 | Morton-Norwich Products, Inc. | 1-Benzyl-3-methyl-3,4,5,6-tetrahydro-2(1H) pyrimidone |
| US4052399A (en) * | 1976-09-13 | 1977-10-04 | Morton-Norwich Products, Inc. | 1-[2-(Hexahydro-1H-azepino)ethyl]-2(1H)pyrimidone dihydrochloride |
| US4052400A (en) * | 1976-10-29 | 1977-10-04 | Morton-Norwich Products, Inc. | Hypertensive 1-substituted 2(1h)-pyrimidones |
| US8835426B2 (en) * | 2007-02-26 | 2014-09-16 | Vitae Pharmaceuticals, Inc. | Cyclic urea and carbamate inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
| CL2008002199A1 (es) * | 2007-07-26 | 2009-10-23 | Vitae Pharmaceuticals Inc | Compuestos derivados de 1,3-oxazin-2-ona; composicion farmaceutica que comprende a dichos compuestos; y uso para tratar una enfermedad asociada con la actividad de la 11beta-hidroxiesteroide deshidrogenasa tipo 1 (11beta-hsd1) tales como dislipidemia, hiperlipidemia, hipertension, obesidad y enfermedad cardiovascular, entre otras. |
| AR069207A1 (es) * | 2007-11-07 | 2010-01-06 | Vitae Pharmaceuticals Inc | Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1 |
| CA2708303A1 (en) | 2007-12-11 | 2009-06-18 | Vitae Pharmaceuticals, Inc. | Cyclic urea inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1 |
| TW200934490A (en) * | 2008-01-07 | 2009-08-16 | Vitae Pharmaceuticals Inc | Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1 |
| US8592409B2 (en) | 2008-01-24 | 2013-11-26 | Vitae Pharmaceuticals, Inc. | Cyclic carbazate and semicarbazide inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
| EP2252598A2 (en) * | 2008-02-11 | 2010-11-24 | Vitae Pharmaceuticals, Inc. | 1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| CA2715290A1 (en) * | 2008-02-15 | 2009-08-20 | Vitae Pharmaceuticals, Inc. | Inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| WO2009117109A1 (en) * | 2008-03-18 | 2009-09-24 | Vitae Pharmaceuticals, Inc. | Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 |
| US8242111B2 (en) * | 2008-05-01 | 2012-08-14 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
| JP5538365B2 (ja) * | 2008-05-01 | 2014-07-02 | ヴァイティー ファーマシューティカルズ，インコーポレイテッド | １１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状阻害剤 |
| TW200946520A (en) * | 2008-05-01 | 2009-11-16 | Vitae Pharmaceuticals Inc | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| EP2291371B1 (en) * | 2008-05-01 | 2015-06-10 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| EP2324017B1 (en) | 2008-07-25 | 2014-12-31 | Boehringer Ingelheim International GmbH | INHIBITORS OF 11beta-HYDROXYSTEROID DEHYDROGENASE 1 |
| CN104327062A (zh) * | 2008-07-25 | 2015-02-04 | 贝林格尔·英格海姆国际有限公司 | 11β-羟基类固醇脱氢酶1的环状抑制剂 |
| CA2729993A1 (en) | 2008-07-25 | 2010-01-28 | Boehringer Ingelheim International Gmbh | Synthesis of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 |
| WO2010127237A2 (en) * | 2009-04-30 | 2010-11-04 | Boehringer Ingelheim International Gmbh | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| US8637505B2 (en) | 2009-02-04 | 2014-01-28 | Boehringer Ingelheim International Gmbh | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| TW201039034A (en) * | 2009-04-27 | 2010-11-01 | Chunghwa Picture Tubes Ltd | Pixel structure and the method of forming the same |
| US8680093B2 (en) | 2009-04-30 | 2014-03-25 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| US8927539B2 (en) | 2009-06-11 | 2015-01-06 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 based on the 1,3-oxazinan-2-one structure |
| US8883778B2 (en) | 2009-07-01 | 2014-11-11 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1 |
| EP2496589B1 (en) | 2009-11-05 | 2014-03-05 | Boehringer Ingelheim International GmbH | Novel chiral phosphorus ligands |
| UY33001A (es) | 2009-11-06 | 2011-05-31 | Boehringer Ingelheim Int | Derivados arilo y heteroarilcarbonilo de hexahidroindenopiridina y octahidrobenzoquinolina |
| US8648192B2 (en) | 2010-05-26 | 2014-02-11 | Boehringer Ingelheim International Gmbh | 2-oxo-1,2-dihydropyridin-4-ylboronic acid derivatives |
| US8933072B2 (en) | 2010-06-16 | 2015-01-13 | Vitae Pharmaceuticals, Inc. | Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use |
| EP2585444B1 (en) | 2010-06-25 | 2014-10-22 | Boehringer Ingelheim International GmbH | Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders |
| CA2813671A1 (en) | 2010-11-02 | 2012-05-10 | Boehringer Ingelheim International Gmbh | Pharmaceutical combinations for the treatment of metabolic disorders |
| TWI537258B (zh) | 2010-11-05 | 2016-06-11 | 百靈佳殷格翰國際股份有限公司 | 六氫茚并吡啶及八氫苯并喹啉之芳基－及雜環芳基羰基衍生物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE562987A (cg-RX-API-DMAC10.html) * | 1956-12-05 | |||
| DE1121617B (de) * | 1959-05-26 | 1962-01-11 | Huels Chemische Werke Ag | Verfahren zur Herstellung von Tetrahydropyrimidin-2-onderivaten |
| DE1545601A1 (de) * | 1965-07-22 | 1969-08-07 | Basf Ag | Verfahren zur Herstellung von Hexahydro-pyrimidinderivaten |
| DE1670368A1 (de) * | 1966-07-16 | 1970-11-05 | Cassella Farbwerke Mainkur Ag | Verfahren zur Herstellung aralkylsubstituierter Lactame und Cyclischer Harnstoffe |
| DE1670241A1 (de) * | 1967-07-01 | 1971-01-28 | Basf Ag | Verfahren zur Herstellung von 2-Oxohexahydropyrimidinen |
-
1970
- 1970-03-05 US US16982A patent/US3681349A/en not_active Expired - Lifetime
-
1971
- 1971-02-15 ZA ZA710928A patent/ZA71928B/xx unknown
- 1971-02-15 IL IL36189A patent/IL36189A0/xx unknown
- 1971-02-25 NL NL7102519A patent/NL7102519A/xx unknown
- 1971-03-02 ES ES388780A patent/ES388780A1/es not_active Expired
- 1971-03-03 BE BE763745A patent/BE763745A/xx unknown
- 1971-03-03 NO NO802/71A patent/NO130728C/no unknown
- 1971-03-04 DE DE2110445A patent/DE2110445C3/de not_active Expired
- 1971-03-04 FR FR7107502A patent/FR2085673B1/fr not_active Expired
- 1971-03-04 SE SE7102758A patent/SE376420B/xx unknown
- 1971-03-04 DK DK100371AA patent/DK127427B/da unknown
- 1971-03-05 CH CH325271A patent/CH555343A/xx not_active IP Right Cessation
- 1971-03-05 AT AT194271A patent/AT305288B/de active
- 1971-04-19 GB GB22882/71A patent/GB1294626A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| US3681349A (en) | 1972-08-01 |
| FR2085673A1 (cg-RX-API-DMAC10.html) | 1971-12-31 |
| NO130728C (cg-RX-API-DMAC10.html) | 1975-01-29 |
| DE2110445C3 (de) | 1975-05-28 |
| DK127427B (da) | 1973-11-05 |
| FR2085673B1 (cg-RX-API-DMAC10.html) | 1974-09-06 |
| DE2110445B2 (de) | 1974-10-10 |
| AT305288B (de) | 1973-02-26 |
| BE763745A (fr) | 1971-09-03 |
| IL36189A0 (en) | 1971-04-28 |
| NO130728B (cg-RX-API-DMAC10.html) | 1974-10-21 |
| ZA71928B (en) | 1972-09-27 |
| DE2110445A1 (de) | 1971-11-04 |
| GB1294626A (en) | 1972-11-01 |
| SE376420B (cg-RX-API-DMAC10.html) | 1975-05-26 |
| ES388780A1 (es) | 1975-03-01 |
| CH555343A (de) | 1974-10-31 |